Clinical Trial

MRS and Medication Response: A Pilot Study

Study Description

MRS and Medication Response: A Pilot Study

We hope to demonstrate that magnetic resonance spectroscopy can detect brain concentration levels of paroxetine (Paxil) or citalopram (Celexa) or escitalopram (Lexapro) in depressed patients.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.

Additional Information

Official Study Title

Magnetic Resonance Spectroscopy and Medication Response: A Pilot Study

Clinical Trial ID

NCT03254342

ParticipAid ID

neg46a